Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LXRX - Lexicon Pharmaceuticals: Blue Sky Aplenty Revenue Not So Much


LXRX - Lexicon Pharmaceuticals: Blue Sky Aplenty Revenue Not So Much

2024-05-28 06:47:51 ET

Summary

  • Lexicon Pharmaceuticals has a strong cash position and multiple late-stage assets.
  • However, the company is facing low revenues and high expenses.
  • Overall, Lexicon Pharmaceuticals' financial situation presents a mixed outlook for the company.

This is my first look at Lexicon Pharmaceuticals ( LXRX ). I am intrigued by its nice cash, its one approved and several late-stage assets. I am disheartened by its measly revenues and its hefty expenses. Its overall story highlights another tough day in pharma land for sure....

For further details see:

Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much
Stock Information

Company Name: Lexicon Pharmaceuticals Inc.
Stock Symbol: LXRX
Market: NASDAQ
Website: lexpharma.com

Menu

LXRX LXRX Quote LXRX Short LXRX News LXRX Articles LXRX Message Board
Get LXRX Alerts

News, Short Squeeze, Breakout and More Instantly...